The Safety and Efficacy of Lucinactant for Inhalation in Premature Neonates 26 to 32 Weeks Gestational Age

Clinical trial NCT02636868 · COMPLETED

Trial details

NCT number: NCT02636868
Sponsor: Windtree Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Respiratory Distress Syndrome

Start date: 2015-12-01
Primary completion: 2017-07-01
Enrollment: 221

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.